Advertisement

Topics

Illumina Picks Genomic Health’s Phil Febbo for Chief Medical Officer

11:32 EDT 14 Mar 2018 | Xconomy

Illumina (NASDAQ: ILMN) has appointed Phil Febbo to serve as chief medical officer of the San Diego genomics technologies company. Febbo most recently worked as chief medical officer of Redwood City, CA-based Genomic Health (NASDAQ: GHDX). Before that, he was a professor of medicine and urology at the University of California, San Francisco.

Original Article: Illumina Picks Genomic Health’s Phil Febbo for Chief Medical Officer

NEXT ARTICLE

More From BioPortfolio on "Illumina Picks Genomic Health’s Phil Febbo for Chief Medical Officer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Urology
Benign Prostatic Hyperplasia (BPH) Erectile Dysfunction Urology Urology is the branch of medicine concerned with the urinary tract and diseases that affect it. Examples include urethritis, urethrostenosis and incontinence. Urology is a su...